Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-006667
Filing Date
2025-03-07
Accepted
2025-03-07 16:07:16
Documents
1
Period of Report
2025-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 10130
  Complete submission text file 0001437749-25-006667.txt   11714
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Issuer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O KERYX BIOPHARMACEUTICALS 750 LEXINGTON AVENUE NEW YORK X1 10022
Business Address
Kaye Jack (Reporting) CIK: 0001376099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32513 | Film No.: 25720071